Herrera, F. (2024) “LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT”, Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024039. doi: 10.4084/MJHID.2024.039.